Giuseppe Ciaramella Ph.D.
Net Worth

Last updated:

What is Giuseppe Ciaramella Ph.D. net worth?

The estimated net worth of Dr. Giuseppe Ciaramella Ph.D. is at least $44,555,906 as of 17 Dec 2024. He owns shares worth $1,790,060 as insider, has earned $39,034,646 from insider trading and has received compensation worth at least $3,731,200 in Beam Therapeutics Inc..

What is the salary of Giuseppe Ciaramella Ph.D.?

Dr. Giuseppe Ciaramella Ph.D. salary is $746,240 per year as Pres & Chief Scientific Officer in Beam Therapeutics Inc..

How old is Giuseppe Ciaramella Ph.D.?

Dr. Giuseppe Ciaramella Ph.D. is 56 years old, born in 1969.

What stocks does Giuseppe Ciaramella Ph.D. currently own?

As insider, Dr. Giuseppe Ciaramella Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
Beam Therapeutics Inc. (BEAM) Pres & Chief Scientific Officer 109,150 $16.4 $1,790,060

What does Beam Therapeutics Inc. do?

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

BEAM logo
BEAM
Beam Therapeutics Inc.
$16.4

Giuseppe Ciaramella Ph.D. insider trading

Beam Therapeutics Inc.

Dr. Giuseppe Ciaramella Ph.D. has made 22 insider trades between 2020-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 155,324 units of BEAM stock on 21 Jul 2023. As of 17 Dec 2024 he still owns at least 109,150 units of BEAM stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 53,500 $0.67 $35,845
Option
Common Stock 53,500 $0.67 $35,845
Sale
Common Stock 51,110 $26.36 $1,347,055
Option
Common Stock 1,457 $7.22 $10,520
Option
Common Stock 12,979 $4.22 $54,771
Option
Common Stock 27,318 $0.67 $18,303
Option
Stock Option (Right to Buy) 41,754 $4.04 $168,561
Sale
Common Stock 51,110 $26.27 $1,342,762
Option
Common Stock 90,900 $0.67 $60,903
Option
Stock Option (Right to Buy) 90,900 $0.67 $60,903
Option
Stock Option (Right to Buy) 1,206 $7.22 $8,707
Sale
Common Stock 1,206 $32.01 $38,604
Option
Common Stock 1,206 $7.22 $8,707
Option
Common Stock 21,846 $7.22 $157,728
Option
Stock Option (Right to Buy) 69,438 $7.22 $501,342
Option
Stock Option (Right to Buy) 21,846 $7.22 $157,728
Sale
Common Stock 155,324 $32.06 $4,979,687
Option
Common Stock 69,438 $7.22 $501,342
Sale
Common Stock 1,754 $29.09 $51,029
Sale
Common Stock 1,918 $30.31 $58,135
Option
Stock Option (Right to Buy) 4,326 $4.22 $18,256
Option
Common Stock 9,106 $0.67 $6,101
Option
Common Stock 4,326 $4.22 $18,256
Option
Common Stock 40,297 $0.67 $26,999
Option
Stock Option (Right to Buy) 40,297 $0.67 $26,999
Sale
Common Stock 600 $39.94 $23,964
Sale
Common Stock 1,900 $39.07 $74,233
Sale
Common Stock 13,704 $37.99 $520,615
Sale
Common Stock 37,525 $37.14 $1,393,679
Option
Stock Option (Right to Buy) 4,500 $0.67 $3,015
Option
Common Stock 4,500 $0.67 $3,015
Sale
Common Stock 13,933 $43.15 $601,209
Option
Stock Option (Right to Buy) 18,211 $0.67 $12,201
Option
Stock Option (Right to Buy) 18,211 $0.67 $12,201
Option
Common Stock 8,652 $4.22 $36,511
Option
Stock Option (Right to Buy) 8,652 $4.22 $36,511
Sale
Common Stock 5,383 $43.87 $236,152
Option
Common Stock 18,211 $0.67 $12,201
Sale
Common Stock 31,699 $42.3 $1,340,868
Sale
Common Stock 1,859 $59.11 $109,885
Option
Stock Option (Right to Buy) 39,700 $0.67 $26,599
Option
Common Stock 39,700 $0.67 $26,599
Sale
Common Stock 2,607 $86.45 $225,375
Option
Stock Option (Right to Buy) 2,607 $7.22 $18,823
Option
Common Stock 2,607 $7.22 $18,823
Option
Stock Option (Right to Buy) 29,393 $7.22 $212,217
Option
Common Stock 25,104 $7.22 $181,251
Sale
Common Stock 25,104 $85.84 $2,154,802
Option
Common Stock 4,289 $7.22 $30,967
Sale
Common Stock 4,289 $85.2 $365,423
Option
Common Stock 18,012 $0.67 $12,068
Option
Stock Option (Right to Buy) 18,012 $0.67 $12,068
Sale
Common Stock 78,580 $106.85 $8,396,587
Sale
Common Stock 78,580 N/A N/A
Sale
Common Stock 78,580 $106.85 $8,396,587
Option
Stock Option (Right to Buy) 78,580 N/A N/A
Option
Common Stock 78,580 N/A N/A
Option
Stock Option (Right to Buy) 4,030 $0.67 $2,700
Option
Common Stock 4,030 $0.67 $2,700
Option
Stock Option (Right to Buy) 55,842 $0.85 $47,466
Option
Stock Option (Right to Buy) 55,842 $0.85 $47,466
Option
Common Stock 55,842 $0.85 $47,466
Sale
Common Stock 43,842 $84.14 $3,688,997
Sale
Common Stock 43,842 $84.14 $3,688,997
Option
Common Stock 3,731 $0.67 $2,500
Option
Stock Option (Right to Buy) 3,731 $0.67 $2,500

Beam Therapeutics key executives

Beam Therapeutics Inc. executives and other stock owners filed with the SEC:

  • Dr. Giuseppe Ciaramella Ph.D. (56) Pres & Chief Scientific Officer
  • Mr. John M. Evans M.B.A. (47) Chief Executive Officer & Director
  • Ms. Terry-Ann Burrell M.B.A. (48) Chief Financial Officer & Treasurer